RxDoctor Payments Data

John Mullinax, MD

Surgery · Tampa, FLNPI 1285825661

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $11,068 of the $12,244 with a category attached, or 90.4%. Merit Medical Systems Inc accounts for 92.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $5,848 and has fallen 95.2% since, to $278 in 2025.

$12,244in general payments, 2019–2025

Across 22 payments — averaging $556.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merit Medical Systems Inc$11K
  • Iovance Biotherapeutics, Inc.$462
  • Aadi Bioscience, Inc.$170
  • Davol Inc.$137
  • Johnson & Johnson$67
  • Baxter Healthcare$39
$1,459,125in research payments, 2019–2025

Across 9 payments — averaging $162,125 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$1.4M
  • Iovance Biotherapeutics, Inc.$20K

What the payments were for

  • Consulting fees$11,06890%
  • Travel & lodging$440%
  • Food & beverage$1,1339%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,244 in reported general payments places this provider in the 75th percentile of 1,569 surgery providers in Florida.

See all surgery providers in Florida

Medicare billing

Part B allowed, 2024
$49,235
Medicare patients
53
Services billed
123

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgery in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →